No Small Cell Lung Cancer
Conditions
Interventions
control group:Silicone emulsion
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Non small cell lung cancers which were dignosised by pathology or cytology; (2) Targeted therapy leading to rash(postoperative or advanced); (3) Aged 18-75 years; (4) Postoperative: ECOG>=0-1, KPS>=80; Advanced: ECOG>=0-3, KPS>=50; (5) prediction survival time: Postoperative: >=6 months, Advanced: >=3 months; (6) Neutrophil>1.5×10^9/L; Platelet>100×10^9/L; HGB>9.0g/dl; TBil normaol or < 1.5 × ULN; AST (SGOT), ALT (SGPT) < 2.5 × ULN; Cr < 1.5 × ULN; (7) Sign the informed consent form,and has good compliance; (8) Accepting molecule targeted medication therapy; Meet the criteria of diagnosis of rash, NCI-CTCAE3.0 assess one or more ranks; Symptom continued more than one day.
Exclusion criteria
Exclusion criteria: (1) Non small cell lung cancers which were not dignosised by pathology or cytology; (2) The pregnant women and lactation period women, psychotic patients; (3) The patient with serious uncontroled organic disease,such as function decompensated of herat, lung, liver, kidney; (4) Under other trials; (5) Allergic to the research medicine.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| remission rate of rash;remission time of rash; | — |
Secondary
| Measure | Time frame |
|---|---|
| quality of life;symptoms of Chinese Medicine;KPS;weight;immune function; | — |
Countries
China
Contacts
Public ContactLin Hongsheng
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed